Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Supplemental material
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article (0)
Advertisement

Corrigendum Open Access | 10.1172/jci.insight.181596

Neuronal deletion of the circadian clock gene Bmal1 induces cell-autonomous dopaminergic neurodegeneration

Michael F. Kanan, Patrick W. Sheehan, Jessica N. Haines, Pedro G. Gomez, Adya Dhuler, Collin J. Nadarajah, Zachary M. Wargel, Brittany M. Freeberg, Hemanth R. Nelvagal, Mariko Izumo, Joseph S. Takahashi, Jonathan D. Cooper, Albert A. Davis, and Erik S. Musiek

Find articles by Kanan, M. in: PubMed | Google Scholar

Find articles by Sheehan, P. in: PubMed | Google Scholar |

Find articles by Haines, J. in: PubMed | Google Scholar

Find articles by Gomez, P. in: PubMed | Google Scholar |

Find articles by Dhuler, A. in: PubMed | Google Scholar

Find articles by Nadarajah, C. in: PubMed | Google Scholar

Find articles by Wargel, Z. in: PubMed | Google Scholar

Find articles by Freeberg, B. in: PubMed | Google Scholar

Find articles by Nelvagal, H. in: PubMed | Google Scholar

Find articles by Izumo, M. in: PubMed | Google Scholar

Find articles by Takahashi, J. in: PubMed | Google Scholar |

Find articles by Cooper, J. in: PubMed | Google Scholar |

Find articles by Davis, A. in: PubMed | Google Scholar

Find articles by Musiek, E. in: PubMed | Google Scholar |

Published August 29, 2024 - More info

Published in Volume 9, Issue 15 on August 8, 2024
JCI Insight. 2024;9(15):e181596. https://doi.org/10.1172/jci.insight.181596.
© 2024 Kanan et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published August 29, 2024 - Version history
View PDF

Related article:

Neuronal deletion of the circadian clock gene Bmal1 induces cell-autonomous dopaminergic neurodegeneration
Michael F. Kanan, … , Albert A. Davis, Erik S. Musiek
Michael F. Kanan, … , Albert A. Davis, Erik S. Musiek
The circadian clock protein BMAL1 regulates survival of dopaminergic neurons in vivo in a cell-autonomous manner.
Research Article Aging Neuroscience Article has an altmetric score of 11

Neuronal deletion of the circadian clock gene Bmal1 induces cell-autonomous dopaminergic neurodegeneration

  • Text
  • PDF
Abstract

Circadian rhythm dysfunction is a hallmark of Parkinson disease (PD), and diminished expression of the core clock gene Bmal1 has been described in patients with PD. BMAL1 is required for core circadian clock function but also serves nonrhythmic functions. Germline Bmal1 deletion can cause brain oxidative stress and synapse loss in mice, and it can exacerbate dopaminergic neurodegeneration in response to the toxin MPTP. Here we examined the effect of cell type–specific Bmal1 deletion on dopaminergic neuron viability in vivo. We observed that global, postnatal deletion of Bmal1 caused spontaneous loss of tyrosine hydroxylase+ (TH+) dopaminergic neurons in the substantia nigra pars compacta (SNpc). This was not replicated by light-induced disruption of behavioral circadian rhythms and was not induced by astrocyte- or microglia-specific Bmal1 deletion. However, either pan-neuronal or TH neuron–specific Bmal1 deletion caused cell-autonomous loss of TH+ neurons in the SNpc. Bmal1 deletion did not change the percentage of TH neuron loss after α-synuclein fibril injection, though Bmal1-KO mice had fewer TH neurons at baseline. Transcriptomics analysis revealed dysregulation of pathways involved in oxidative phosphorylation and Parkinson disease. These findings demonstrate a cell-autonomous role for BMAL1 in regulating dopaminergic neuronal survival and may have important implications for neuroprotection in PD.

Authors

Michael F. Kanan, Patrick W. Sheehan, Jessica N. Haines, Pedro G. Gomez, Adya Dhuler, Collin J. Nadarajah, Zachary M. Wargel, Brittany M. Freeberg, Hemanth R. Nelvagal, Mariko Izumo, Joseph S. Takahashi, Jonathan D. Cooper, Albert A. Davis, Erik S. Musiek

×

Original citation JCI Insight. 2024;9(2):e162771. https://doi.org/10.1172/jci.insight.162771

Citation for this corrigendum: JCI Insight. 2024;9(15):e181596. https://doi.org/10.1172/jci.insight.181596

The authors recently became aware of an inadvertent error in presentation of representative TH- and cresyl violet–stained images in Supplemental Figure 2C. The correct panels are shown below. The authors confirm that the quantification is correct and the conclusions of the study are not affected.

The Supplemental data has been updated online.

The authors regret the error.

Supplemental material

View Supplemental data

Footnotes

See the related article at Neuronal deletion of the circadian clock gene Bmal1 induces cell-autonomous dopaminergic neurodegeneration.

Version history
  • Version 1 (August 29, 2024): Electronic Publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (0)

Go to

  • Top
  • Supplemental material
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts

Posted by 19 X users
31 readers on Mendeley
See more details